Ken Hall takes a look at two big-name retirement shares in the FTSE 100 with market-leading positions and track records of ...
18h
Hosted on MSNStudy Finds Exenatide Not Beneficial for Parkinson DiseaseThe glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity, ...
It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results